IDENTIFICATION OF NOVEL THERAPEUTIC DRUGS IN DISTINCT PEDIATRIC AML SUBTYPES BY TARGETING EPIGENETIC REGULATORS

被引：0
|
作者：
Wiggers, C. [1 ,2 ]
Lelieveld, D. [3 ]
Egan, D. [3 ]
Bartels, M. [1 ]
机构：
[1] Univ Med Ctr Utrecht, Pediat, Utrecht, Netherlands
[2] Hubrecht Inst, Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Cell Screening Core, Cell Biol, Utrecht, Netherlands
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E901
引用
收藏
页码：370 / 370
页数：1
相关论文
共 50 条
  • [21] Identification and proteogenomic characterization of novel lung adenocarcinoma subtypes with therapeutic relevance
    Roh, Whijae
    Geffen, Yifat
    Miller, Mendy
    Anand, Shankara
    Kim, Jaegil
    Heiman, David
    Meyerson, Matthew
    Laird, Peter
    Cherniack, Andrew
    Getz, Gad
    CANCER RESEARCH, 2022, 82 (12)
  • [22] Identification of human adenovirus replication inhibitors from a library of small molecules targeting cellular epigenetic regulators
    Saha, Bratati
    Parks, Robin J.
    VIROLOGY, 2021, 555 : 102 - 110
  • [23] Therapeutic advancements in targeting BCL-2 family proteins by epigenetic regulators, natural, and synthetic agents in cancer
    Sarkar, Arnab
    Paul, Abhik
    Banerjee, Tanmoy
    Maji, Avik
    Saha, Sanjukta
    Bishayee, Anupam
    Maity, Tapan Kumar
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 944
  • [24] Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor
    Cawston, Erin E.
    Miller, Laurence J.
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 159 (05) : 1009 - 1021
  • [25] Therapeutic potential of novel selective drugs targeting nicotinic acetylcholine receptors
    Merouane Bencherif
    Terry A. Hauser
    Kristen G. Jordan
    Gregory J. Gatto
    Journal of Molecular Neuroscience, 2006, 30 : 17 - 18
  • [26] Therapeutic potential of novel selective drugs targeting nicotinic acetylcholine receptors
    Bencherif, Merouane
    Hauser, Terry A.
    Jordan, Kristen G.
    Gatto, Gregory J.
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2006, 30 (1-2) : 17 - 18
  • [27] Targeting MYC as a novel therapeutic strategy for an epigenetic-driven cancer: NUT Carcinoma
    Escudero-Iriarte, Carmen
    Castro, Joel
    Beniavides-Puy, Iker
    Tissera, Natalia S.
    Querol-Panos, Jessica
    Agusti, Irene
    Whitfield, Jonathan R.
    Vieito, Maria
    Nonell, Lara
    Macarulla, Teresa
    Brana, Irene
    Soucek, Laura
    Tian, Tian V.
    CANCER RESEARCH, 2024, 84 (06)
  • [28] Identification of Two Novel Immune Subtypes Characterized by Distinct Prognosis and Tumor Microenvironment in Osteosarcoma
    Yao, Shunhan
    Deng, Meiling
    Du, Xiaojing
    Chen, Qingfeng
    Huang, Rongzhi
    JOURNAL OF IMMUNOLOGY RESEARCH, 2022, 2022
  • [29] Whole exome sequencing identifies novel mutations of epigenetic regulators in chemorefractory pediatric acute myeloid leukemia
    Zhan, Di
    Zhang, Yingchi
    Xiao, Peifang
    Zheng, Xinchang
    Ruan, Min
    Zhang, Jingliao
    Chen, Aili
    Zou, Yao
    Chen, Yumei
    Huang, Gang
    Hu, Shaoyan
    Wang, Qian-fei
    Zhu, Xiaofan
    LEUKEMIA RESEARCH, 2018, 65 : 20 - 24
  • [30] Identification of Novel Drugs Targeting Cell Cycle Regulators for the Treatment of High-Grade Serous Ovarian Cancer via Integrated Bioinformatics Analysis
    Zhao, Yuanchun
    Zuo, Jiachen
    Shen, Yiming
    Yan, Donghui
    Chen, Jiajia
    Qi, Xin
    SYMMETRY-BASEL, 2022, 14 (07):
12345